Science ❯ Pharmacology

Drug Development

Clinical Trials Clinical Research Clinical Studies Clinical Applications L-Dopa Clinical Testing Smoking Cessation Aids Cancer Therapeutics GLP-1 Medications Sildenafil Combination Therapy Oral Medications Therapeutic Effects Antimicrobial Resistance Drug Design Weight Loss Drugs

Novel Non-Opioid Analgesic ADRIANA Advances to U.S. Phase II Trials

The α2B-adrenoceptor blocker moves into large-scale U.S. Phase II testing after early Japanese trials showed it to be safe with maintained efficacy.